University of Manitoba: Annual Report 1999-2000 - Research Highlights-University Innovations at Work
CoverUniversity of Manitoba Annual Report 1999-2000

University Innovations at Work

A key role of the Industry Liaison Office (ILO) is to identify, protect and market academic innovations. In 1999-2000, royalty income from the existing 69 licenses and options totalled $1,329,996. Currently, 211 worldwide patents (pending or issues) are being managed by ILO, 104 of which have been issued. In 1999-2000, the University of Manitoba issued six patents:

Lorne Brandes, internal medicine and the Manitoba Institute of Cell Biology, was issued a patent in Canada for improved treatment methods for abnormal cells and a patent in Australia for a method of treatment of hormone-unresponsive metastatic prostate cancer.

Robert Matusik, formerly with the department of physiology, received two United States patents for a transgenic mouse model for prostate cancer.

Lotfollah Shafai, electrical and computer engineering, was awarded a United States patent for a microstrip line fed microstrip end-fire antenna.

Krishnamurti Dakshinamurti, biochemistry and medical genetics, and Naranjan Dhalla, physiology, received a United States patent for the treatment of ischemia reperfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction.

 

 


Brodie Centre
Brodie Centre
Previous SectionPrevious PageHome - Annual ReportNext PageNext Section
George Bowden, dentistry
7.0 7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 7.9 7.10 7.11 7.12